The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells

Oncogene

Volumn 16, Issue 12, 1998, Pages 1617-1624

  Zhang, Christine C ^a,d   Yang, Jin Ming ^a,d   White, Eileen ^b,d   Murphy, Maureen ^c   Levine, Arnold ^c   Hait, William N ^a,d  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c PRINCETON UNIVERSITY   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Drug sensitivity; MAP4; Microtubule polymerization; p53

Indexed keywords

ANTINEOPLASTIC AGENT; MICROTUBULE ASSOCIATED PROTEIN 4; MUTANT PROTEIN; PACLITAXEL; VINBLASTINE; VINCA ALKALOID; VINCRISTINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DRUG BINDING; DRUG RESISTANCE; DRUG SENSITIVITY; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE TEST; MICROTUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALIA; MURINAE; VINCA;

EID: 0032568221     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201658     Document Type: Article

References (42)

1. Aas T, Borresen A-L, Geisler S, Smith-Sonrensen B, Johnson H, Vargaug JE, Akslen LA and Lonning PE. (1996). Nature Med., 2, 811-814.
2. Baker SJ, Markowitz S, Fearon ER, Wilson JK and Vogelstein B. (1990). Science, 249, 912-915.
3. Chapin SL, Lue CM and Bulinski JC. (1995). Biochemistry, 34, 2289-2301.
4. Clarke AS, Gledhill ML, Hooper CC, Bird and Wyllie AH. (1993). Nature, 362, 849-952.
5. Debbas N and White E. (1993). Genes & Dev., 7, 546-554.
6. Delia D, Mizutani S, Lamorte G, Goi K, Iwata S and Pierotti MA. (1996). Nature Med., 2, 724-725.
7. Fan S, El-Diery WS, Bao I, Freeman J, Jondle D, Bhatia K, Fornace AJ, Magrath I, Kohn KW and O'Conner PM. (1994). Cancer Res., 54, 5824-5830.
8. Fan S, Smith ML, Rivet II DJ, Duba D, Zhan Q, Kohn KW, Fornace Jr AJ and O'Conner PM. (1996). Cancer Res., 55, 1649-1654.
9. Gewitz DA. (1993). Oncology Res., 5, 397-408.
10. Gupta RS. (1985). J. Natl. Cancer Inst., 71, 159-164.
11. Gupta RS. (1988). Biochem. Biophys. Res. Commun., 153, 598-605.
12. Hall PA, McKee PH, Menage HD, Dover R and Lane DP. (1993). Oncogene, 8, 203-207.
13. Hartwell L. (1992). Cell, 71, 543-546.
14. Hawkins DS, Demer WD and Galloway DA. (1996). Cancer Res., 56, 892-898.
15. Horwitz SB. (1992). Trends Pharmacol. Sci., 13, 134-136.
16. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig W. (1991). Cancer Res., 51, 6304-6311.
17. Kastan MB, Zhan Q, El-Diery WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace Jr AJ. (1992). Cell, 71, 587-597.
18. Kondo S, Yin D, Morimura T, Oda Y, Kikuchi H and Takeeuchi J. (1994). Cancer Res., 54, 2928-2933.
19. Lane DP. (1993). Nature, 362, 786-787.
20. Lee JM and Bernstein A. (1993). Proc. Natl. Acad. Sci. USA, 90, 5742-5746.
21. Lee S, Elenbaas B, Levine AJ and Griffith J. (1995). Cell. 81, 1013-1020.
22. Levine AJ. (1997). Cell, 88, 323-331.
23. Lin D, Shields MT, Ullrich SJ, Appella E and Mercer WE. (1992). Proc. Natl. Acad. Sci. USA, 89, 9210-9214.
24. Lobert S, Vulevic B and Correia JJ. (1996). Biochemistry, 35, 6806-6814.
25. Lowe SW, Ruley HE, Jack T and Housman DE. (1993). Cell, 74, 957-967.
26. Lutzker S and Levine A. (1996). Drug resistance (Cancer treatment and research). Edition 1, Kluwer Acad. Publishers: Norwell, MA., pp, 345-357.
27. Merritt AJ, Rotten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP and Hall PA. (1994). Cancer Res., 54, 614-617.
28. Mosmann T. (1983). J. Immunol. Methods, 65, 55-63.
29. Murphy M, Hinman A and Levine A. (1996). Genes & Dev., 10, 2971-2980.
30. Nguyen HL, Chari S, Gruber D, Luce CM, Chapin SJ and Bulinski JC. (1997). J. Cell. Sci., 110, 281-294.
31. Perry ME and Levine AJ. (1993). Curr. Opin. in Genet. Dev., 3, 50-54.
32. Sabbatini P, Lin J, Levine AJ and White E. (1995). Genes & Dev., 9, 2184-2192.
33. Sabbatini P, Han J, Chiou SK, Nicholson DW and White E. (1997). Cell Growth Differ, 8, 643-653.
34. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D and Boyd MR. (1988). Cancer Res., 48, 4827-4833.
35. Tishler RB, Lamppu DM, Park S and Price BD. (1995). Cancer Res., 55, 6021-6025.
36. Volgelstein B and Kinzler KW. (1992). Cell, 70, 523-526.
37. Wahl AF, Donaldson KL, Fairchild C, Lee F-YF Foster SA, Demers GW and Galloway DA. (1996). Nature Medicine, 2, 72-79.
38. Waldman T, Lengauer C, Kinzler KW and Vogelstein B. (1996). Nature, 381, 713-716.
39. White E. (1996). Genes & Dev., 10, 1-15.
40. Wu GS and El-Diery WS. (1996). Nature Med., 2, 255-256.
41. Yoshida T, Imanaka-Yoshida K, Murofushi H, Tanaka J, Ito H and Inagaki M. (1996). Cell Motil. Cytoskeleton, 33, 252-262.
42. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T and Brash DE. (1994). Nature, 372, 773-776.